An in-depth look to PHARMSVILLE CO., LTD. operating, investing, and financing activities

318010 free cash flow for Q3 24 is -182.1 M KRW. For 2023, 318010 free cash flow was 4.46 B KRW and operating cash flow was 4.65 B KRW.